Fludeoxyglucose F 18 Injection
Product Images NDC 67939-010

Fludeoxyglucose F 18 Injection, USP is a sterile, non-pyrogenic diagnostic used for intravenous use. It is a multiple-dose vial containing Fludeoxyglucose F 18 and 45 mg of sodium chloride in citrate buffer. The concentration ranges from 20 mCi/mL to 300 mCi/mL at EOS* and each mL contains .74 GBq to 11.1 GBq of no-carrier added. It has a half-life of 109.7 minutes. The calibration date and time is indicated and the correct dosage is calculated from the date and time of calibration. It should be stored upright in two shielded containers at 25°C (T7°F). Aseptically withdraw 2nd handle doses; do not use if cloudy or if it contains particulate matter. Manufactured by The University of Utah DBA Cyclotron Radiochemistry Lab in Salt Lake City, UT. 84112.*

This is a description of a medical product, specifically the NDC 67939-010-50 Multiple-Dose Vial of Fludeoxyglucose F 18 Injection, USP. It is used for diagnostic purposes through intravenous use only. The product contains sterile, non-pyrogenic fludeoxyglucose F 18 and sodium chloride in a citrate buffer. The dosages range from 20 mCi to 300 mCi, which contains .74 GBq to 11.1 GBq of no-carrier added with a half-life of 109.7 minutes. It should be stored upright and in a shielded container at 25°C (T7°F). The calibration time and date should be taken into account when calculating the correct dosage. Not available.*

NDC 67939-010-50 is a Multiple-Dose Vial of Fludeoxyglucose F 18 Injection, USP, used for diagnostic purposes. It is a sterile and non-pyrogenic injection for intravenous use only. The injection has a concentration of mCi/ml and can have an activity range of 20mCi/ml to 300mCi/ml at EOS*. The injection has a short half-life of 109.7 minutes and contains fludeoxyglucose F 18, 45mg of sodium chloride, and citrate buffer. It should be stored upright in two shielded containers and at 25°C (T7°F). The correct dosage should be calculated from the date and time of calibration. The calibration (EOS*) time needs to be recorded, and the expiration time is 12 hours after EOS*. The University of Utah DBA Cyclotron Radiochemistry Lab manufactures this product. "CAUTION: RADIOACTIVE MATERIAL /A | P e s ExoNLY" is written on the label.*

Fludeoxyglucose F 18 Injection, USP is a sterile and non-pyrogenic diagnostic injection used for intravenous purpose only. This injection is available in NDC 67939-010-50 Multiple-Dose Vial and contains varying concentrations of 20 mCifnL to 300 mCiimL @ EOS*. The injection is stored at 25°C (T7°F) (see insert) and contains Fludeoxyglucose F 18, 45 mg of sodium chloride, and citrate buffer [18F]. The half-life of [18F] is 109.7 minutes. Correct dosage calculation must be done from the date and time of calibration. The injection should not be used if it's cloudy or contains particulate matter. Calibration (EOS*) time and Calibration Date details are printed on the injection. The injection needs to be stored upright in two shielded container handles for aseptic withdrawal. Note that EOS= End of Synthesis. The manufacturer of the injection is The University of Utah DBA Cyclotron Radiochemistry Lab. This product contains radioactive material and is for use only by authorized persons.*